Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway

PLoS ONE - United States
doi 10.1371/journal.pone.0062823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway

Chinese Medicine
2018English

LncRNA SNHG6 Inhibits Cell Proliferation and Metastasis by Targeting ETS1 via the PI3K/AKT/mTOR Pathway in Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Dihydroartemisinin and Gefitinib Synergistically Inhibit NSCLC Cell Growth and Promote Apoptosis via the Akt/mTOR/Stat3 Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

EFEMP1 Promotes Ovarian Cancer Cell Growth, Invasion and Metastasis via Activated the AKT Pathway

Oncotarget
Oncology
2016English

Overexpression of CAPN2 Promotes Cell Metastasis and Proliferation via AKT/mTOR Signaling in Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Serine Protease From Nereis Virens Inhibits H1299 Lung Cancer Cell Proliferation via the PI3K/AKT/mTOR Pathway

Marine Drugs
Drug Discovery
2019English

Cyclovirobuxine D Inhibits Colorectal Cancer Tumorigenesis via the CTHRC1‑AKT/ERK‑Snail Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2020English

Adiponectin Inhibits Colorectal Cancer Cell Growth Through the AMPK/mTOR Pathway

International Journal of Oncology
Cancer ResearchOncology
1992English

Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy